No Data
No Data
Beijing Tongrentang Co., Ltd Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Investors in Beijing Tongrentang Co., Ltd (SHSE:600085) had a good week, as its shares rose 3.7% to close at CN¥42.33 following the release of its first-quarter results. Revenues of CN¥5.3b fell
Tong Ren Tang Registers Danggui Buxue Granules in Hong Kong
Beijing Tong Ren Tang Group (SHA:600085) received the certificate of registration from Hong Kong's Chinese Medicine Council for Danggui Buxue granules, according to the company's filing on the Shangha
Does Beijing Tongrentang (SHSE:600085) Deserve A Spot On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Unfortun
Tong Ren Tang Chinese Medicine (03613): Issued a certificate of registration for proprietary Chinese medicines
According to Zhitong Finance App, Tong Ren Tang Sinopharm (03613) issued an announcement. The company recently received the “Certificate of Registration for Proprietary Chinese Medicines” issued by the Hong Kong Traditional Chinese Medicine Administration, which allows the sale of “Angelica Blood Supplementation Granules [Tong Ren Tang]” in Hong Kong.
Express News | Tong Ren Tang: Holding Sun Company obtained the Hong Kong Proprietary Chinese Medicine Registration Certificate for Angelica Blood Supplements
Tong Ren Tang (600085.SH): “Angelica Blood Supplement Granules [Tong Ren Tang]” obtained the Hong Kong Proprietary Chinese Medicine Registration Certificate
Zhitong Finance App News, Tong Ren Tang (600085.SH) issued an announcement. Recently, Beijing Tongrentang Sinopharm Co., Ltd. (hereinafter referred to as Tongrentang Sinopharm), the company's holding company, received the “Certificate of Registration for Proprietary Chinese Medicine” issued by the Hong Kong Traditional Chinese Medicine Administration, permitting the sale of “Angelica Blood Supplement Granules [Tong Ren Tang]” in Hong Kong. According to the announcement, after receiving the registration certificate for proprietary Chinese medicines issued by the Hong Kong Traditional Chinese Medicine Administration, Tongrentang Sinopharm's angelica blood supplement granules “Tong Ren Tang” can be sold in Hong Kong, which will help enrich its product line and facilitate its market expansion. The one with the above registration certificate
No Data